Where does Aurobindo Pharma Ltd rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Aurobindo Pharma Ltd ranks #11,929 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Aurobindo Pharma Ltd hold?

Aurobindo Pharma Ltd holds 25 US utility patents granted between 2015 and 2025, spanning 11 technology areas.

What is Aurobindo Pharma Ltd's Innovation Score?

Aurobindo Pharma Ltd has an Innovation Score of 30.0 out of 100 (33rd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Aurobindo Pharma Ltd focus on?

Aurobindo Pharma Ltd's top technology area is C07D (Heterocyclic Compounds) with 15 patents, ranking #570 of 3,165 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

Is Aurobindo Pharma Ltd's patent grant rate increasing or decreasing?

Aurobindo Pharma Ltd's recent grant velocity is +129% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Aurobindo Pharma Ltd's patents?

Aurobindo Pharma Ltd's patents average 6.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Aurobindo Pharma Ltd patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Aurobindo Pharma Ltd

USPTO PatentsView assignee record - 25 granted patents across 11 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Aurobindo ranks #11,929 of 49,997 tracked US assignees by granted-patent volume, with 25 patents across 11 technology areas.

#11,929
of 49,997 US assignees by volume: 33rd percentile
by Innovation Score (30.0/100): 6.6
avg claims per patent: +129%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11929 · Foreign Corporation #11,929 · 25 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 25 grants
UPPER-Q #11,929/49,997
PHOTO-FINISH Ariosa Diagnostics
CPC-FOCUS C07D · 11 areas
INNOV-THIN 30.0/100
CLAIMS-SPARSE 6.6 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +129% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ariosa Diagnostics, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Aurobindo’s 30.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.3 pts (38%) Velocity 3.1 pts (10%) Breadth 11.7 pts (39%) Claim depth 4.0 pts (13%)

Qualcomm Incorporated · highest

85
Abbyy InfoPoisk · near

30
Aurobindo Pharma · this assignee

30
Epigenomics · near

30
UBE Machinery · near

30
Skyhigh Networks · near

30
3D Lighting… · lowest

7

What this shows Aurobindo's Innovation Score is 30.0/100 (33rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Aurobindo?

Each dot is one of Aurobindo’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Aurobindo’s own 6.6 claims/patent is at or below the 12.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Aurobindo vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Aurobindo's grants concentrate

Aurobindo Pharma Ltd is a focused PatentsView assignee: 11 CPC subclasses with 60% of grants classified under C07D (Heterocyclic Compounds). Peak complete grant year is 2021 (6 grants) versus a trough of 1 in 2015. By volume, Aurobindo sits between Ariosa Diagnostics, Inc. and Bedoukian Research, Inc..

Aurobindo's three-year grant acceleration

Aurobindo Pharma Ltd shows 6 grants in 2022–2024 against only 13 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Ariosa Diagnostics

25
Arla Foods Amba

25
Aspen Surgical Pr…

25
Attopsemi Technol…

25
Autifony Therapeu…

25
Aventics

25
Barilla G & R Fra…

25
Bedoukian Research

25
Aurobindo Pharma ◀

25

What this shows Aurobindo holds 25 patents at rank #11,930, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Aurobindo

By rank, the assignees closest to #11,930 in granted patent volume.

Leaders in C07D (Heterocyclic Compounds)

Other assignees with the most granted patents in Aurobindo's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Aurobindo, neither rank-band nor same-CPC leaders (those blocks stay above). In C07D (Heterocyclic Compounds), Aurobindo ranks #570 of 3,165 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (30 here).

UBE Machinery Corporation, Ltd. 30 Epigenomics AG 30 Skyhigh Networks, LLC 30 Abbyy InfoPoisk LLC 30

Aurobindo's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 33rd percentile higher than 33% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Aurobindo Pharma Ltd patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	4.0%
2017	2	8.0%
2018	1	4.0%
2019	3	12.0%
2020	4	16.0%
2021	6	24.0%
2022	2	8.0%
2023	1	4.0%
2024	3	12.0%
2025partial year	2	8.0%

Which technologies does Aurobindo Pharma Ltd patent most?

C07D - Heterocyclic Compounds 15

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 12

C07C - Acyclic OR Carbocyclic Compounds 6

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 4

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 4

C08G - Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds 2

B01D - Separation 1

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 1

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 1

B32B - Layered Products, i.e. Products Built-up OF Strata OF Flat OR Non-flat, e.g. Cellular OR Honeycomb, Form 1

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Aurobindo Pharma Ltd's patent record in context - here's where to go next.

Aurobindo Pharma Ltd's lead technology class is C07D (Heterocyclic Compounds), 60% of its portfolio - see every assignee active in that class. Explore C07D
Ranked #11,929 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Aurobindo Pharma Ltd against Ariosa Diagnostics, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 30.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.